M-M-R II Vaccine

Generic name: measles, mumps, and rubella virus vaccine live
Dosage form: njection, powder, lyophilized, for suspension
Drug class:Vaccine combinations

Medically reviewed by Drugs.com. Last updated on May 1, 2022.

Indications and Usage for M-M-R II Vaccine

M-M-R® II is a vaccine indicated for active immunization for the prevention of measles, mumps, and rubella in individuals 12 months of age and older.

M-M-R II Vaccine Dosage and Administration

For subcutaneous use only.

Dose and Schedule

Each 0.5 mL dose is administered subcutaneously.

The first dose is administered at 12 to 15 months of age. A second dose is administered at 4 to 6 years of age.

The second dose may be administered prior to 4 years of age, provided that there is a minimum interval of one month between the doses of measles, mumps and rubella virus vaccine, live {1-2}.

Children who received an initial dose of measles, mumps and rubella vaccine prior to their first birthday should receive additional doses of vaccine at 12-15 months of age and at 4-6 years of age to complete the vaccination series [see Clinical Studies (14.2)].

For post-exposure prophylaxis for measles, administer a dose of M-M-R II Vaccine within 72 hours after exposure.

Preparation and Administration

Use a sterile syringe free of preservatives, antiseptics, and detergents for each injection and/or reconstitution of the vaccine because these substances may inactivate the live virus vaccine. To reconstitute, use only the diluent supplied with the vaccine since it is free of preservatives or other antiviral substances which might inactivate the vaccine.

Withdraw the entire volume of the supplied diluent from its vial and inject into lyophilized vaccine vial. Agitate to dissolve completely. Discard if the lyophilized vaccine cannot be dissolved.

Withdraw the entire volume of the reconstituted vaccine and inject subcutaneously into the oute...